Consolidated figures · ₹ crore
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 21,794 | 25,229 | |
| COGS | 4,111 | 4,733 | 5,499 | 5,684 | 7,573 | 8,574 | 9,806 | 11,310 | 13,076 |
| Gross profit | 4,133 | 4,885 | 5,748 | 4,876 | 7,089 | 8,038 | 9,254 | 10,484 | 12,153 |
| 3,339 | 3,821 | 4,164 | 3,738 | 4,897 | 6,032 | 6,845 | 7,429 | 8,339 | |
| 793 | 1,064 | 1,584 | 1,138 | 2,192 | 2,006 | 2,409 | 3,055 | 3,814 | |
| OPM % | 9.6% | 11.1% | 14.1% | 10.8% | 15% | 12.1% | 12.6% | 14% | 15.1% |
| Depreciation | 359 | 396 | 620 | 573 | 601 | 615 | 687 | 758 | 876 |
| Interest | 295 | 327 | 533 | 449 | 379 | 381 | 449 | 459 | 450 |
| 32 | 31 | 225 | 106 | 372 | 90 | 108 | 200 | 172 | |
| Profit before tax | 171 | — | 657 | 221 | 1,585 | 1,101 | 1,381 | 2,039 | 2,661 |
| Tax | 112 | 173 | 225 | 85 | 477 | 256 | 446 | 534 | 658 |
| Tax % | 65.3% | — | 34.3% | 38.2% | 30.1% | 23.3% | 32.3% | 26.2% | 24.7% |
| 60 | 199 | 432 | 137 | 1,108 | 845 | 935 | 1,505 | 2,003 | |
| PAT margin % | 0.7% | 2.1% | 3.8% | 1.3% | 7.6% | 5.1% | 4.9% | 6.9% | 7.9% |
| EPS (₹) | — | — | 32.7 | 10.7 | 73.4 | 57 | 62.5 | 100.6 | 135 |
| EPS adjusted (₹) | 8.4 | 17 | 32.7 | 10.5 | 73.4 | 57 | 62.5 | 100.6 | 135 |
| — | — | 18.3% | 27.9% | 16% | 26.3% | 25.6% | 18.9% | 14.8% | |
| Annual report | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 3,384 | 3,240 | 3,182 | 3,264 | 3,269 | 4,531 | 5,551 | 6,125 | 6,864 | 8,140 | 9,408 |
| Minority interest | — | 128 | 132 | 135 | 131 | 200 | 254 | 334 | 385 | 441 | 494 |
| 2,478 | 3,024 | 3,303 | 3,450 | 3,350 | 2,859 | 2,636 | 2,710 | 3,162 | 5,275 | 5,659 | |
| 1,756 | 1,657 | 1,926 | 2,264 | 4,519 | 3,755 | 4,679 | 5,186 | 6,271 | 6,729 | 6,564 | |
| Total equity & liabilities | 7,687 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,192 | 14,428 | 16,753 | 20,657 | 22,197 |
| 3,613 | 4,583 | 4,766 | 4,975 | 5,779 | 5,789 | 7,192 | 8,516 | 9,661 | 10,985 | 12,269 | |
| CWIP | 596 | 347 | 712 | 822 | 209 | 212 | 44 | 602 | 845 | 771 | 992 |
| Investments | 270 | 106 | 58 | 69 | 440 | 1,348 | 784 | 578 | 990 | 2,490 | 2,181 |
| 3,209 | 3,083 | 3,077 | 3,317 | 4,910 | 4,068 | 5,172 | 4,733 | 5,258 | 6,411 | 6,755 | |
| Total assets | 7,687 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,192 | 14,428 | 16,753 | 20,657 | 22,197 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Healthcare services | 12,750.1 | 2,430.3 | 14,486.2 | 3,935.7 | 10,550.5 | 23.03 |
| Digital health & pharmacy distribution | 10,808.1 | 398.7 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 423 | 632 | 539 | 905 | 1,293 | 1,273 | 1,616 | 1,377 | 1,920 | 2,136 | 2,856 | |
| -684 | -804 | -378 | -711 | -289 | -872 | -791 | -857 | -1,537 | -3,381 | -2,148 | |
| 272 | 130 | -106 | -215 | -910 | -340 | -768 | -633 | -311 | 1,317 | -478 | |
| Net cash flow | 12 | — | 54 | -20 | 95 | 61 | 57 | -113 | 72 | 73 | 230 |
| Free cash flow | -408 | 54 | 21 | 226 | 780 | 978 | 958 | 249 | 784 | 424 | 894 |
| CFO / Operating profit % | — | — | 67.9% | 85.1% | 81.5% | 112% | 73.9% | 67.2% | 80.3% | 70.7% | 75.8% |
| 3,318.1 |
| 946.6 |
| 2,371.5 |
| 16.81 |
| Retail health & diagnostics | 1,865.3 | 72.3 | 1,473.2 | 1,143.6 | 329.6 | 21.94 |
| Others | 5.2 | -8.1 | 25.7 | 18.3 | 7.4 | -109.46 |
₹ crore by fiscal year